Tatton Brown Rahman Syndrome (TBRS) Community Inc.’s Post

Don't miss our webinar hosted by HFMA, with AGS Health's VP of Coding Services, @Leigh Poland, tomorrow at 2:00 pm CT, focusing on MIPS Reporting. With rules changing yearly, navigating MIPS can be challenging. Discover key 2024 changes and best practices for documentation, performance, and revenue. Don't miss out—sign up today. https://hubs.ly/Q02vmB1q0

Exciting news! Our annual conference is coming 👇 ⭐ 💃 Spread the news and follow our LinkedIn page or X (@DiagnosticsNE) for latest updates

The Magnetic Message Triad™ A huge thanks to everyone who attended yesterday’s LIVE! To recap, we covered: 1. How I create positioning in the community to consistently attract cash-pay patients who pay over $300/visit 2. Two-steps to becoming “a market of one” and beacon for niche patients in your community while filtering out poor-quality patients 3. How to avoid the need to use low ticket offers to book new patients If you missed it, head to the link below to watch the replay and grab a copy of the worksheets! https://lnkd.in/eK-MnhAb

The Digital Technology Assessment Criteria (DTAC) is a vital framework used by the NHS to evaluate digital health innovations. It ensures that digital technology procured by the NHS is secure, technically robust, clinically safe, and accessible for everyone. 💙 We had the pleasure of working with the Peerr team to create a series of videos about the DTAC, covering the basics and more. Watch below to hear Naq Co-founder and CEO Nadia answer: "What are some of the considerations companies need to take on board when undergoing the DTAC process?" ⬇️

At PSI, we understand the importance of building authentic and meaningful site relationships. Making sites feel heard and supported boosts patient enrollment and engagement through team enthusiasm and optimism. Learn how to harness the power of positive site relationships in our white paper: https://bit.ly/3TV6GjN

Register below if you'd like to hear our thoughts on changes in the NHS in 2024 and how this may impact access to medicines and treatments for patients! Let us know what your thoughts! #lifescienceindustry #nhspartnership #accesstotreatment

Very useful place to start if you are currently brand or strat planning in lifescience. This conversation discusses policy implications impacting onthe pharma industry specifically.... There will be another one out shortly looking from a medtech perspective.

🌍 Calling all healthcare professionals! Enhance your expertise in caring for EDS and HSD patients with the EDS ECHO Multidisciplinary Team Practice: Europe Program. ⁠ ⁠ 🌟 Led by experts Assoc. Prof. Dr. Alan Hakim and Prof. Jane Simmonds, this program offers comprehensive modules on diagnosis, treatment, and collaboration across disciplines. Improve patient outcomes through evidence-based practices and connect with peers worldwide. The next program begins September 17 looking at Neuro-musculoskeletal Concerns. Program topics will include: ● Complications of the Cervical and Thoracic Spine ● Craniocervical Instability ● TMJ and Dental Concerns ● Speech and Swallow Disorders ● Shoulder Instability ● Wrist and Hand Dysfunction ⁠ CME/CEU/CE credits are available to healthcare professionals. Credits are awarded at 1 per 60 minutes of live session activity.⁠ ⁠ 📅 Learn more and register: https://lnkd.in/gGVCCYvs ⁠ Through these programs, the Ehlers-Danlos Society aims to foster collaboration and improve the care and quality of life for those with EDS and HSD.

The largest volume of NHS activity is in primary care. GPs see at least 1 million patients a day. Commercial studies in Primary Care offer significant benefits to the NHS. By integrating clinical research into everyday healthcare, these studies provide patients with early access to innovative treatments and therapies. Our NIHR (National Institute for Health and Care Research) leads for Primary Care , Residential and Care Settings will ensure that Commercial contract studies will not only enhance patient care but generate substantial income and cost savings for the NHS. The Association of the British Pharmaceutical Industry (ABPI) has highlighted James O'Shaughnessy's independent review which emphasizes the critical role of research in primary care, highlighting its potential to transform patient outcomes and enhance healthcare delivery. He noted that integrating research into primary care settings allows for more inclusive and diverse participation in clinical trials, leading to more comprehensive and applicable results. #ResearchReady #PrimaryCareResearch

In their new Forefront article, Olivia Thomas, Jacob Mirsky, Norma Gonzalez, Benaye Wadkins, and Jaclyn Albin from Boston Medical Center (BMC), Massachusetts General Hospital, UT Southwestern Medical Center, and Crossroads Community Services argue that, by advancing the integration of Food Is Medicine in health care through community collaboration, we can significantly enhance patient outcomes, improve health care delivery, and proactively address future health challenges. "We work as direct-service providers in hospital systems and community-based organizations (CBOs) and have experience implementing FIM interventions in health care settings. And we believe that it is possible to elevate the current FIM movement, help tackle food insecurity at its roots, support health equity, and ensure sustainable care models that mitigate strain on health care organizations and providers. To that end, we offer three guiding principles, developed through our own experience, trial and tribulation to ensure the success of Food Is Medicine." Read the full article here: https://bit.ly/484axBY